Ahmed W, Katz S (2016) Therapeutic Use of Cannabis in Inflammatory Bowel Disease. Gastroenterol Hepatol 12:668–679

Google Scholar 

Al-Ghezi ZZ, Miranda K, Nagarkatti M, Nagarkatti PS (2019) Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Front Immunol 10:1921. https://doi.org/10.3389/fimmu.2019.01921

CAS  Article  PubMed  PubMed Central  Google Scholar 

Aranami T, Yamamura T (2008) Th17 Cells and Autoimmune Encephalomyelitis (EAE/MS). Allergol Int 57:115–120. https://doi.org/10.2332/allergolint.R-07-159

CAS  Article  PubMed  Google Scholar 

Becker W, Alrafas HR, Busbee PB et al (2020a) Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis jjaa253. https://doi.org/10.1093/ecco-jcc/jjaa253

Becker W, Alrafas HR, Wilson K et al (2020b) Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production. iScience 23:101504. https://doi.org/10.1016/j.isci.2020.101504

Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157:121–141. https://doi.org/10.1016/j.cell.2014.03.011

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bellnier T, Brown GW, Ortega TR (2018) Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Ment Health Clin 8:110–115. https://doi.org/10.9740/mhc.2018.05.110

Article  PubMed  PubMed Central  Google Scholar 

Bolyen E, Rideout JR, Dillon MR et al (2019) Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37:852–857. https://doi.org/10.1038/s41587-019-0209-9

CAS  Article  PubMed  PubMed Central  Google Scholar 

Boziki MK, Kesidou E, Theotokis P et al (2020) Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know. Brain Sci. https://doi.org/10.3390/brainsci10040234

Article  PubMed  PubMed Central  Google Scholar 

Broz P, Pelegrín P, Shao F (2019) The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. https://doi.org/10.1038/s41577-019-0228-2

Article  PubMed  Google Scholar 

Bruni N, Della Pepa C, Oliaro-Bosso S et al (2018) Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Mol Basel Switz. https://doi.org/10.3390/molecules23102478

Article  Google Scholar 

Butler A, Hoffman P, Smibert P et al (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411–420. https://doi.org/10.1038/nbt.4096

CAS  Article  PubMed  PubMed Central  Google Scholar 

Constantinescu CS, Farooqi N, O’Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079–1106. https://doi.org/10.1111/j.1476-5381.2011.01302.x

CAS  Article  PubMed  PubMed Central  Google Scholar 

Corey-Bloom J, Wolfson T, Gamst A et al (2012) Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ Can Med Assoc J J Assoc Medicale Can 184:1143–1150. https://doi.org/10.1503/cmaj.110837

Article  Google Scholar 

Cripps JG, Gorham JD (2011) MDSC in autoimmunity. Int Immunopharmacol 11:789–793. https://doi.org/10.1016/j.intimp.2011.01.026

CAS  Article  PubMed  PubMed Central  Google Scholar 

Crook KR, Liu P (2014) Role of myeloid-derived suppressor cells in autoimmune disease. World J Immunol 4:26–33. https://doi.org/10.5411/wji.v4.i1.26

Article  PubMed  PubMed Central  Google Scholar 

Dargahi N, Katsara M, Tselios T et al (2017) Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sci. https://doi.org/10.3390/brainsci7070078

Article  PubMed  PubMed Central  Google Scholar 

Ding J, Wang K, Liu W et al (2016) Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535:111–116. https://doi.org/10.1038/nature18590

CAS  Article  PubMed  Google Scholar 

Dopkins N, Becker W, Miranda K et al (2020) Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor. Front Pharmacol 11:619265. https://doi.org/10.3389/fphar.2020.619265

CAS  Article  PubMed  Google Scholar 

Dopkins N, Nagarkatti PS, Nagarkatti M (2018) The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology 154:178–185. https://doi.org/10.1111/imm.12903

CAS  Article  PubMed  PubMed Central  Google Scholar 

Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS (2018) Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells. Front Immunol 9:1782. https://doi.org/10.3389/fimmu.2018.01782

CAS  Article  PubMed  PubMed Central  Google Scholar 

Erben U, Loddenkemper C, Doerfel K et al (2014) A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol 7:4557–4576

PubMed  PubMed Central  Google Scholar 

Fajas L, Auboeuf D, Raspé E et al (1997) The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene. J Biol Chem 272:18779–18789. https://doi.org/10.1074/jbc.272.30.18779

CAS  Article  PubMed  Google Scholar 

Fletcher JM, Lalor SJ, Sweeney CM et al (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162:1–11. https://doi.org/10.1111/j.1365-2249.2010.04143.x

CAS  Article  PubMed  PubMed Central  Google Scholar 

Fournier BM, Parkos CA (2012) The role of neutrophils during intestinal inflammation. Mucosal Immunol 5:354–366. https://doi.org/10.1038/mi.2012.24

CAS  Article  PubMed  Google Scholar 

Gérikas Ribeiro C, Lopes dos Santos A, Marie D et al (2016) Pico and nanoplankton abundance and carbon stocks along the Brazilian Bight. PeerJ 4:e2587. https://doi.org/10.7717/peerj.2587

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ghasemi N, Razavi S, Nikzad E (2017) Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J 19:1–10. https://doi.org/10.22074/cellj.2016.4867

Article  PubMed  Google Scholar 

Goldenberg MM (2012) Multiple sclerosis review. P T Peer-Rev J Formul Manag 37:175–184

Google Scholar 

Greenson JK, Stern RA, Carpenter SL, Barnett JL (1997) The clinical significance of focal active colitis. Hum Pathol 28:729–733. https://doi.org/10.1016/s0046-8177(97)90183-0

CAS  Article  PubMed  Google Scholar 

Grygiel-Górniak B (2014) Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications–a review. Nutr J 13:17. https://doi.org/10.1186/1475-2891-13-17

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hartung DM, Bourdette DN, Ahmed SM, Whitham RH (2015) The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail? Neurology 84:2185–2192. https://doi.org/10.1212/WNL.0000000000001608

Article  PubMed  PubMed Central  Google Scholar 

Hegde VL, Nagarkatti PS, Nagarkatti M (2011) Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PloS One 6:e18281. https://doi.org/10.1371/journal.pone.0018281

CAS  Article  PubMed  PubMed Central  Google Scholar 

Heming M, Gran S, Jauch S-L et al (2018) Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids. Front Immunol 9:893. https://doi.org/10.3389/fimmu.2018.00893

CAS  Article  PubMed  PubMed Central  Google Scholar 

Herz J, Filiano AJ, Smith A et al (2017) Myeloid Cells in the Central Nervous System. Immunity 46:943–956. https://doi.org/10.1016/j.immuni.2017.06.007

CAS  Article  PubMed  PubMed Central  Google Scholar 

Huang W-J, Chen W-W, Zhang X (2017) Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med 13:3163–3166. https://doi.org/10.3892/etm.2017.4410

Article  PubMed  PubMed Central  Google Scholar 

Ioannou M, Alissafi T, Lazaridis I et al (2012) Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease. J Immunol 188:1136–1146. https://doi.org/10.4049/jimmunol.1101816

CAS  Article  PubMed  Google Scholar 

Kadowaki A, Quintana FJ (2020) The Gut-CNS Axis in Multiple Sclerosis. Trends Neurosci 43:622–634. https://doi.org/10.1016/j.tins.2020.06.002

CAS  Article  PubMed  PubMed Central  Google Scholar 

Leweke FM, Piomelli D, Pahlisch F et al (2012) Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2:e94. https://doi.org/10.1038/tp.2012.15

CAS  Article  PubMed  PubMed Central  Google Scholar 

Li H-D, Chen X, Yang Y et al (2017) Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease. Int Immunopharmacol 50:95–106. https://doi.org/10.1016/j.intimp.2017.06.013

CAS  Article  PubMed  Google Scholar 

Lublin F, Miller DH, Freedman MS et al (2016) Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Lond Engl 387:1075–1084. https://doi.org/10.1016/S0140-6736(15)01314-8

CAS  Article  Google Scholar 

Maroon J, Bost J (2018) Review of the neurological benefits of phytocannabinoids. Surg Neurol Int 9:91. https://doi.org/10.4103/s